{"material": "SECOND AMENDED AND RESTATED CHARTER OF  \n\nKING PHARMACEUTICALS, INC.,  \n\nAS AMENDED\n\n\n\nPursuant to the provisions of Section 48-20-107 of the Tennessee Business\n\nCorporation Act, Tennessee Code Annotated, the undersigned Corporation hereby\n\nadopts the following Second Amended and Restated Charter:\n\n\n\n1\\. Name. The name of the Corporation is: King Pharmaceuticals, Inc.\n\n\n\n2\\. Authorized Shares. (a)The total number of shares of common stock that the\n\nCorporation shall have authority to issue is 600,000,000, no par value (the\n\n\u0093Common Stock\u0094). The total number of shares of preferred stock that the\n\nCorporation shall have authority to issue is 15,000,000, no par value per\n\nshare (the \u0093Preferred Stock\u0094).\n\n\n\n(b) The common Stock shall rank junior to the Preferred Stock in right of\n\npayment of dividends and upon liquidation and is subject to all the powers,\n\nrights, privileges, preferences and priorities of the Preferred Stock as\n\nprovided herein or in any resolutions or resolutions or adopted by the Board\n\nof Directors pursuant to authority expressly vested in it by the provisions of\n\nsubparagraph (c) of this Paragraph 2.\n\n\n\n(c) Authority is hereby expressly vested in the Board of Directors of the\n\nCorporation, subject to the provisions of this Paragraph 2 and to the\n\nlimitations prescribed by law, to authorize the issuance from time to time of\n\none or more series of Preferred Stock. The authority of the Board of Directors\n\nwith respect to each series shall include, but not be limited to, the\n\ndetermination or fixing of the following by resolution or resolutions adopted\n\nby the affirmative vote of a majority of the total number of the directors\n\nthen in office:\n\n\n\n(i) The designation of such series;\n\n\n\n(ii) The dividend rate of such series, the conditions and dates upon which\n\nsuch dividends shall be payable, the relation which such dividends shall bear\n\nto the dividends payable on any other class or classes or series of the\n\nCorporation\u0092s capital stock, and whether such dividends shall be cumulative or\n\nnoncumulative;\n\n\n\n(iii) Whether the shares of such series shall be subject to redemption for\n\ncash, property or rights, including securities of any other corporation, by\n\nthe Corporation, or upon the happening of a specified event, and, if made\n\nsubject to any such redemption, the times or events, prices, rates,\n\nadjustments and other terms and conditions of such redemptions;\n\n\n\n* * *\n\n\n\n#####  \n\n\n\n(iv) The terms and amount of any sinking fund provided for the purchase or\n\nredemption of the shares of such series;\n\n\n\n(v)Whether or not the shares of such series shall be convertible into, or\n\nexchangeable for, at the option of either the holder or the Corporation or\n\nupon the happening of a specified event, shares of any other class or classes\n\nor of any other series of the same or any other class or classes of the\n\nCorporation\u0092s capital stock, and, if provision be made for conversion or\n\nexchange, the times or events, prices, rates, adjustments and other terms and\n\nconditions of such conversions or exchanges;\n\n\n\n(vi) The restrictions, if any, on the issue or reissue of any additional\n\nseries of Preferred Stock;\n\n\n\n(vii) The rights of the holders of the shares of such series upon the\n\nvoluntary or involuntary liquidation, dissolution or winding up of the\n\nCorporation; and\n\n\n\n(viii) The provisions as to voting, optional and/or other special rights and\n\npreferences, if any, including, without limitation, the right to elect one or\n\nmore directors.\n\n\n\n3\\. Registered Office. The address of the Corporation\u0092s registered office in\n\nthe State of Tennessee shall be 501 Fifth Street, Bristol, Tennessee 37620,\n\nSullivan County.\n\n\n\n4\\. Registered Agent. The name of the registered agent at that office is John\n\nA.A. Bellamy.\n\n\n\n5\\. Principal Office. The address of the principal office of the Corporation\n\nis 501 Fifth Street, Bristol, Tennessee 37620, Sullivan County.\n\n\n\n6\\. Board of Directors. The number of directors shall be fixed by resolution\n\nof the Board of Directors. The directors of the Corporation shall be divided\n\ninto three classes: Class I, Class II and Class III. Membership in such\n\nclasses shall be as nearly equal in number as possible. The term of office of\n\nthe initial Class I directors shall expire at the annual election of directors\n\nby shareholders of the Corporation in 1998, the term of office of the initial\n\nClass II directors shall expire at the annual election of directors by\n\nshareholders of the Corporation in 1999, the term of office of the initial\n\nClass III directors shall expire at the annual election of directors by\n\nshareholders of the Corporation in 2000, or thereafter when their respective\n\nsuccessors in each case are elected by the shareholders and qualified,\n\nsubject, however, to prior death, resignation, retirement, disqualification or\n\nremoval from office with or without cause. At each succeeding annual election\n\nof directors by the shareholders of the Corporation beginning in 1997, the\n\ndirectors chosen to succeed those whose terms then expire shall be identified\n\nas being of the same class as the directors they succeed and shall be elected\n\nfor a term expiring at the third\n\n\n\n* * *\n\n\n\n#####  \n\n\n\nsucceeding annual election of directors by the shareholders of the\n\nCorporation, or thereafter when their respective successors in each case are\n\nelected by the shareholders and qualified. If the number of directors is\n\nchanged, any increase or decrease shall be apportioned among the classes so as\n\nto maintain the number of directors in each class as nearly equal as possible,\n\nand any additional director of any class elected to fill a vacancy resulting\n\nfrom an increase in such class shall hold office for a term that shall\n\ncoincide with the remaining term of that class, but in no case will a decrease\n\nin the number of directors shorten the term of any incumbent director.\n\n\n\n7\\. For Profit: Duration. The Corporation is for profit and its duration shall\n\nbe perpetual.\n\n\n\n8\\. Director Liability. No director of the Corporation shall have or owe any\n\npersonal liability to the Corporation or its shareholders for monetary damages\n\nfor breach of fiduciary duty as a director; provided, that such provision\n\nshall not eliminate or limit the liability of a director:\n\n\n\na. For any breach of the director\u0092s duty of loyalty to the Corporation or its\n\nshareholders;\n\n\n\nb. For acts or omissions not in good faith or which involve intentional\n\nmisconduct or a knowing violation of law; or\n\n\n\nc. Under Tennessee Code Annotated \u00a748-18-304, as such provision may be amended\n\nfrom time to time..\n\n\n\n9\\. Indemnification. Each director, officer, and employee of the Corporation\n\nshall be entitled to all indemnification rights and protections now or\n\nhereafter available under applicable Tennessee law.\n\n\n\n10\\. Section 6 and this Section 10 of this Second Amended and Restated Charter\n\nand Sections 2 and 6 of Article I and Section 3 of Article II of the Amended\n\nand Restated Bylaws of the Corporation shall not be altered, amended or\n\nrepealed by, and no provision inconsistent therewith shall be adopted by, the\n\nshareholders without the affirmative vote of the holders of at least 80% of\n\nthe Common Stock, voting together as a single class.\n\n\n\n11\\. These amendments shall be effective as of the filing of this Second\n\nAmended and Restated Charter.\n\n\n\n12\\. This restatement contains amendments requiring shareholder approval and\n\nthese amendments were duly adopted by the shareholders at a meeting duly\n\ncalled on the 14th day of November, 1997.\n\n\n\n* * *\n\n\n\n#####  \n\n\n\nThe undersigned submits this Second Amended and Restated Charter of King\n\nPharmaceuticals, Inc., to the State of Tennessee with the right, powers and\n\nprivileges herein declared.\n\n\n\nDated: November 14, 1997\n\n\n\n|  |  |  |  \n\n---|---|---|---|---  \n\n| KING PHARMACEUTICALS, INC.  \n\n|  \n\n| By:  | /s/ John A. A. Bellamy  |  \n\n|  | John A. A. Bellamy  |  \n\n|  | Assistant Secretary to the Board of  \n\nDirectors &  \n\nExecutive Vice President and  \n\nGeneral Counsel  |\n\n", "completion": {"answer": "Y", "reference": ["No director of the Corporation shall have or owe any personal liability to the Corporation or its shareholders for monetary damages for breach of fiduciary duty as a director;"], "reason": "The charter explicitly states that no director shall have personal liability for monetary damages for breach of fiduciary duty, which constitutes a 102(b)(7) waiver.", "confidence": 5}, "ground_truth": "Y"}